Records containing: Parkinson's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-08-27A Randomized Controlled Feasibility Trial to Determine the Effectiveness of Set Dancing for People With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2013-08-20Nocturnal Parkinson's Disease Symptoms Study Group
-
CLINICAL_TRIALS study record update · 2013-08-02Deep Brain Stimulation Effects: Human Proof-of-Concept Study
-
CLINICAL_TRIALS study record update · 2013-08-02Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2013-07-30An Open-Label Multicenter Study of the Continued Safety of Istradefylline (KW-6002) In Subjects With Parkinson's Disease Who Have Recently Completed One Year of Treatment With Istradefylline.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-07-30CSP #468 Phase I - A Comparison of Best Medical Therapy and Deep Brain Stimulation of Subthalamic Nucleus and Globus Pallidus for the Treatment of Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2013-07-19A Phase IIa, 12 Week, Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2013-06-26Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2013-06-19High Frequency rTMS (Repetitive Transcranial Magnetic Stimulation) Effect Applied on Primary Cortical Motor, on Nociceptive Perception Thresholds in Parkinson's Disease Patients: a Physiopathology Study
-
CLINICAL_TRIALS study record update · 2013-06-11A Long-Term, Multicenter, Open-Label Safety Study With Oral 20 or 40 mg/d Doses of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa Therapy
-
CLINICAL_TRIALS study record update · 2013-05-31Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone
-
CLINICAL_TRIALS study record update · 2013-05-30Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2013-05-20A Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Trimethobenzamide (Tigan®) in the Control of Nausea and Vomiting During Initiation and Continued Treatment With Subcutaneous Apomorphine (Apokyn®) in Apomorphine-naïve Subjects With Parkinson's Disease Suffering From Acute Intermittent "Off" Episodes, With Phased Withdrawal of Subjects From Tigan® to Placebo
-
CLINICAL_TRIALS study record update · 2013-05-17Neuroimaging Studies of Depression in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2013-05-14Nicotine Treatment of Impulsivity in Parkinson's Disease: A Pilot Study
-
CLINICAL_TRIALS study record update · 2013-05-13A Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin®, Administered Using Stereotactic Injection to the Striatum of Patients With Bilateral, Idiopathic Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2013-04-15Non-Interventional, Retrospective, Multi-center Study to Evaluate Non-Motor Symptoms in Advanced PD Patients Already Treated With Rotigotine
-
CLINICAL_TRIALS study record update · 2013-04-12A Randomised, Multicenter 12-Week Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness in Parkinson's Disease Followed by a 38 Week Open Label Extension Phase
-
CLINICAL_TRIALS study record update · 2013-04-12A Randomized, Multicenter 12-Week Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness in Parkinson's Disease Followed by a 38-Week Open-label Extension Phase
-
CLINICAL_TRIALS study record update · 2013-03-29A Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose Escalation Trial to Explore the Potential Antidyskinetic Properties of Safinamide in Patients With Parkinson's Disease Suffering From Levodopa Induced Dyskinesias
-
CLINICAL_TRIALS study record update · 2013-03-12ClinicalTrials.gov study NCT01356056
-
CLINICAL_TRIALS study record update · 2013-03-11A Phase 2 Trial of Florbetapir F18 PET Imaging of β-amyloid in Parkinson's Disease Patients With Cognitive Impairment
-
CLINICAL_TRIALS study record update · 2013-03-04Phase II, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety and Tolerability of PYM50028 in Subjects With Early-stage Parkinson's Disease Administered Once Daily for 28 Weeks
-
CLINICAL_TRIALS study record update · 2013-02-05A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of E2007 In Patients With Parkinson's Disease Who Experience End-of-Dose "Wearing-Off" Motor Fluctuations
-
CLINICAL_TRIALS study record update · 2013-02-05A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations